BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38744744)

  • 1. Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia.
    Lipshitz M; Visser J; Anderson R; Nel DG; Smit T; Steel HC; Rapoport BL
    Support Care Cancer; 2024 May; 32(6):349. PubMed ID: 38744744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging markers of cancer cachexia and their relationship to sarcopenia.
    Lipshitz M; Visser J; Anderson R; Nel DG; Smit T; Steel HC; Rapoport B
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17511-17527. PubMed ID: 37906352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument.
    Arrieta O; Luvián-Morales J; Turcott JG; Oñate-Ocaña LF
    Qual Life Res; 2018 Oct; 27(10):2709-2718. PubMed ID: 29987501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite.
    Blauwhoff-Buskermolen S; Ruijgrok C; Ostelo RW; de Vet HCW; Verheul HMW; de van der Schueren MAE; Langius JAE
    Support Care Cancer; 2016 Feb; 24(2):661-666. PubMed ID: 26160463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
    LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
    Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Life and Symptom Burden Improve in Patients Attending a Multidisciplinary Clinical Service for Cancer Cachexia: A Retrospective Observational Review.
    Bland KA; Harrison M; Zopf EM; Sousa MS; Currow DC; Ely M; Agar M; Butcher BE; Vaughan V; Dowd A; Martin P
    J Pain Symptom Manage; 2021 Sep; 62(3):e164-e176. PubMed ID: 33652095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.
    Paulsen Ø; Laird B; Aass N; Lea T; Fayers P; Kaasa S; Klepstad P
    PLoS One; 2017; 12(5):e0177620. PubMed ID: 28542626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial.
    Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS
    Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES.
    Nanava N; Betaneli M; Giorgobiani G; Chikovani T; Janikashvili N
    Georgian Med News; 2020 May; (302):39-44. PubMed ID: 32672687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
    Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
    Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Thrombo-inflammatory Biomarkers in the Prognosis of Cerebral Venous Sinus Thrombosis.
    Karahan SZ; Gazioglu S; Dilaver I; Boz C
    Curr Neurovasc Res; 2021; 18(2):237-243. PubMed ID: 34109909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
    Mantovani G; Macciò A; Madeddu C; Gramignano G; Lusso MR; Serpe R; Massa E; Astara G; Deiana L
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1030-4. PubMed ID: 16702388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.
    Zhou T; Yang K; Thapa S; Fu Q; Jiang Y; Yu S
    Support Care Cancer; 2017 Apr; 25(4):1183-1189. PubMed ID: 27900546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD.
    Karadeniz H; Güler AA; Kardaş RC; Karadeniz M; Paşaoğlu H; Küçük H; Göker B; Tufan A; Öztürk MA
    Turk J Med Sci; 2023 Jun; 53(3):666-674. PubMed ID: 37476904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
    Chang VT; Xia Q; Kasimis B
    J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease.
    Ahbap E; Sakaci T; Kara E; Sahutoglu T; Koc Y; Basturk T; Sevinc M; Akgol C; Kayalar AO; Ucar ZA; Bayraktar F; Unsal A
    Clin Nephrol; 2016 Apr; 85(4):199-208. PubMed ID: 26521887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19].
    Salman E; Çelikbilek N; Aydoğan S; Özdem B; Gökay S; Kırca F; Toyran A; Bilici Salman R; Dinç B
    Mikrobiyol Bul; 2021 Oct; 55(4):539-552. PubMed ID: 34666654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.